632 related articles for article (PubMed ID: 15530129)
21. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
[TBL] [Abstract][Full Text] [Related]
22. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics of analgesics: toward the individualization of prescription.
Rollason V; Samer C; Piguet V; Dayer P; Desmeules J
Pharmacogenomics; 2008 Jul; 9(7):905-33. PubMed ID: 18597654
[TBL] [Abstract][Full Text] [Related]
24. [Genetic polymorphisms and opioid therapies].
Landau R
Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
[TBL] [Abstract][Full Text] [Related]
25. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects.
Poulsen L; Brøsen K; Arendt-Nielsen L; Gram LF; Elbaek K; Sindrup SH
Eur J Clin Pharmacol; 1996; 51(3-4):289-95. PubMed ID: 9010701
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacology of tramadol.
Grond S; Sablotzki A
Clin Pharmacokinet; 2004; 43(13):879-923. PubMed ID: 15509185
[TBL] [Abstract][Full Text] [Related]
27. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
28. Is there a role for therapeutic drug monitoring with codeine?
Kelly LE; Madadi P
Ther Drug Monit; 2012 Jun; 34(3):249-56. PubMed ID: 22569351
[TBL] [Abstract][Full Text] [Related]
29. CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids.
Knisely MR; Carpenter JS; Draucker CB; Skaar T; Broome ME; Holmes AM; Von Ah D
Appl Nurs Res; 2017 Dec; 38():107-110. PubMed ID: 29241501
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomics of oxycodone: a narrative literature review.
Umukoro NN; Aruldhas BW; Rossos R; Pawale D; Renschler JS; Sadhasivam S
Pharmacogenomics; 2021 Apr; 22(5):275-290. PubMed ID: 33728947
[TBL] [Abstract][Full Text] [Related]
32. Are poor metabolisers of sparteine/debrisoquine less pain tolerant than extensive metabolisers?
Sindrup SH; Poulsen L; Brøsen K; Arendt-Nielsen L; Gram LF
Pain; 1993 Jun; 53(3):335-339. PubMed ID: 8351162
[TBL] [Abstract][Full Text] [Related]
33. Differential Consequences of Tramadol in Overdosing: Dilemma of a Polymorphic Cytochrome P450 2D6-Mediated Substrate.
Srinivas NR
J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):272-5. PubMed ID: 26367475
[TBL] [Abstract][Full Text] [Related]
34. [Genetic polymorphism and drug interactions: their importance in the treatment of pain].
Samer CF; Piguet V; Dayer P; Desmeules JA
Can J Anaesth; 2005 Oct; 52(8):806-21. PubMed ID: 16189332
[TBL] [Abstract][Full Text] [Related]
35. Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial.
Fulton CR; Zang Y; Desta Z; Rosenman MB; Holmes AM; Decker BS; Zhang Y; T Callaghan J; Pratt VM; Levy KD; Gufford BT; Dexter PR; Skaar TC; Eadon MT
Pharmacogenomics; 2019 Apr; 20(6):397-408. PubMed ID: 30784356
[No Abstract] [Full Text] [Related]
36. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC
Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.
Hajj A; Khabbaz L; Laplanche JL; Peoc'h K
Pharmacogenomics; 2013 Apr; 14(5):575-85. PubMed ID: 23556453
[TBL] [Abstract][Full Text] [Related]
38. Individualizing analgesic prescription Part I: pharmacogenetics of opioid analgesics.
Samer CF; Desmeules JA; Dayer P
Per Med; 2006 Aug; 3(3):239-269. PubMed ID: 29788657
[TBL] [Abstract][Full Text] [Related]
39. Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study.
Pedersen RS; Damkier P; Brosen K
Clin Pharmacol Ther; 2005 Jun; 77(6):458-67. PubMed ID: 15961977
[TBL] [Abstract][Full Text] [Related]
40. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
